Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 179-184

  Kernodle, Douglas S ^a,b,c   Voladri, Rama K R ^a   Menzies, Barbara E ^a,c   Hager, Cynthia C ^b   Edwards, Kathryn M ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; COMPLEMENTARY RNA; STAPHYLOCOCCUS VACCINE;

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; VACCINE PRODUCTION;

EID: 0031022928     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.179-184.1997     Document Type: Article

References (41)

1. Alunni-Fabbroni, M., G. Manfioletti, G. Manzini, and L. E. Xodo. 1994. Inhibition of T7 RNA polymerase transcription by phosphate and phospho7 rothioate triplex-forming oligonucleotides targeted to a R ̇ Y site down-stream from the promoter. Eur. J. Biochem. 226:831-839.
2. Bass, B. L., and H. Weintraub. 1988. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55:1089-1098.
3. Bernheimer, A. W. 1988. Assay of hemolytic toxins. Methods Enzymol. 165: 213-217.
4. Bernheimer, A. W. 1965. Staphylococcal alpha toxin. Ann. N. Y. Acad. Sci. 128:112-123.
5. Bhakdi, S., and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733-751.
6. Bradford, M. M. 1976. A rapid and sensitive method for the determination of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
7. Cagnon, L., M. Cucchiarini, J.-C. Lefebvre, and A. Doglio. 1995. Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule. J. AIDS Hum. Retrovirol. 9:349-358.
8. Cassidy, P., and S. Harshman. 1976. Purification of staphylococcal alphatoxin by adsorption chromalography on glass. Infect. Immun. 13:982-986.
9. Day, A. G., E. R. Bejarano, K. W. Buck, M. Burrell, and C. P. Lichtenstein. 1991. Expression of an antisense viral gene in transgenic tobacco confers resistance to the DNA virus tomato golden mosaic virus. Proc. Natl. Acad. Sci. USA 88:6721-6725.
10. Ekstedt, R. D. 1972. Immunity to the staphylococci, p. 385-392. In J. O. Cohen (ed.), The staphylococci. John Wiley & Sons, Inc., New York.
11. Falkow, S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2):S274-S276.
12. Foster, T. J., M. O'Reilly, P. Phonimdaeng, J. Cooney, A. H. Patel, and A. J. Bramley. 1990. Genetic studies of virulence factors of Stapliylococcus aureus: properties of coagulase, γ-toxin, α-toxin, β-toxin, and protein A in the pathogenesis of Staphylococcus aures infections, p. 403-417. In R. P. Novick (ed.), Molecular biology of the staphylococci, VCH Publishers, Inc., New York, N.Y.
13. Gaillard, J. L., P. Berche, and P. Sansonetti. 1986. Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect. Immun. 52:50-55.
14. Galli, D. M., and D. J. LeBlanc. 1995. Transcriptional analysis of rolling circle replicating plasmid pVT736-1: evidence for replication control by antisense RNA. J. Bacteriol. 177:4474-4480.
15. Hanahan, D. 1983. Studies on the transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
16. Hélène, C. 1994. Control of oncogenc expression by antisense nucleic acids. Eur. J. Cancer 30A:1721-1726.
17. Horinouchi. S., and B. Weisblum. 1982. Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics. J. Bacteriol. 150:804-814.
18. Isberg, R. R., and S. Falkow. 1985. Genetic analysis of bacterial virulence determinants in Bordetella pertussis and the pathogenic Yersinia. Curr. Top. Microbiol. Immunol. 118:1-11.
19. Kaplan, E. L., and P. Meier. 1958. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:456-481.
20. Kehoe, M., J. Duncan, T. Foster, N. Fairweather, and G. Dougan. 1983. Cloning, expression, and mapping of the Staphylococcus aureus α-hemolysin determinant in Escherichia coli K-12. Infect. Immun. 41:1105-1111.
21. Lee, C. Y., S. L. Buranen, and Z. H. Ye. 1991. Construction of single-copy integration vectors for Staphylococcus aureus. Gene 103:101-105.
22. Lee, M. H., L. Pascopella, W. R. Jacobs, Jr., and G. F. Hatfull. 1991. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmulis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. Proc. Natl. Acad. Sci. USA 88:3111-3115.
23. Maekawa, T., S. Kimura, K. Hirakawa, A. Murakami, G. Zon, and T. Abe. 1995. Sequence specificity on the growth suppression and induction of apoptosis of chronic mycloid leukemia cells by BCR-ARL anti-sense oligode-oxynucleoside phosphorothioates. Int. J. Cancer 62:63-69.
24. Menzies, B. E., and D. S. Kernodle. 1994. Site-directed mutagenesis of the alpha-toxin gene ol Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. Infect. Immun. 62:1843-1847.
25. Menzies, B. E., and D. S. Kernodle. 1996. Passive immunization with antiserum to a nonloxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect. Immun. 64:1839-1841.
26. Newland, J. W., B. A. Green, and R. K. Holmes. 1984. Transposon-mediated mutagenesis and recombination in Vibrio cholerae. Infect. Immun. 45:428-432.
27. Novick, R. P. 1990. The staphylococcus as a molecular genetic system, p. 1-37. Iu R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers, Inc., New York. N.Y.
28. O'Reilly, M., and T. J. Foster. 1988. Transformation of bacterial protoplasts. FEMS Symp. 40:203-204.
29. Patel, A. H., P. Nowlan, E. D. Weavers, and T. Foster. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:3103-3110.
30. Ramazeilles, C., R. K. Mishra, S. Moreau, E. Pascolo, and J.-J. Touliné. 1994. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leislhmania amazonensis. Proc. Natl. Acad. Sci. USA 91:7859-7863.
31. Ramírez, J. C., J. F. Santarén, and J. M. Almendral. 1995. Transcriptional inhibition of the parvovirus minute virus of mice by constitutive expression of an antisense RNA targeted against the NS-1 transactivator protein. Virology 206:57-68.
32. Ratajczak, M. Z., J. A. Kant, S. M. Luger, N. Hijiya, J. Zhang, G. Zon, and A. M. Gewirtz. 1992. In vivo treatment of human leukemia in a scid mouse model with c-myd antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 89:11823-11827:
33. Rossi, J. J. 1995. Therapeutic antisense and ribozymes. Br. Med. Bull. 51: 217-225.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, N.Y.
35. Smith, C. J., C. F. Watson, P. C. Morris, C. R. Bird, G. B. Seymour, J. E. Gray, C. Arnold, G. A. Tucker, W. Schuch, S. Harding, et al. 1990. Inheritance and effect on ripening of antisense polygalacturonase genes in transgenic tomatoes. Plant Mol. Biol. 14:369-379.
36. Stein, C. A., and Y.-C. Cheng. 1993. Antisense oligonucleotidces as therapeutic agents - is the bullet realK magical? Science 261:1004-1012.
37. Wagner, E. G, H., and R. W. Simons, 1994. Antisense RNA control in bacteria, phages, and plasmids. Annu. Rev Microbiol. 48:713-742.
38. Wagner, R. W., J. E. Smith, B. S. Cooperman, and K. Nishikura. 1989. A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversion in mammalian cells and Xenopus eggs. Proc. Natl. Acail. Sci. USA 86:2647-2651.
39. Weichold, F. F., J. Lisziewica, R. A. Zeman, L. S. Nerurkar, S. Agrawal, M. S. Reitz, Jr., and R. C. Gall. 1995. Antisense phosphorothioate oligode-oxynucletides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 11:863-867.
40. Whitton, J. L. 1994. Anisense treatment of viral infection. Adv. Virus Res. 44:267-303.
41. Zamecnik, P. C., J. Goodchild, Y. Taguchi, and P. S. Sarin. 1986. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc. Natl. Acad. Sci. USA 84:7706-7710.